|
Post by compound26 on Oct 19, 2016 14:49:35 GMT -5
It was not ruined by the doctor IMO. That's what this thread is all about. Tell that to Laura who has had tons of people calling her! And read Mike's post^. It's going out to other stations. @sportsrancho Agree. I think the doctor did ok. OK he is not super excited about Afrezza, but that's just the reality, otherwise our scripts wouldn't be at the current levels. Additionally, the video says he has less than 5% of his patients on Afrezza, which suggests he has some of his patients on Afrezza. Even if at less than 5%, say 3-4%, he is still doing better than most Endos in terms of supporting Afrezza. There are about 1.2-1.4 million T1s in the US. If we capture 3-4% of the T1s, that will be 40,000 to 50,000 T1s on Afrezza, probably 10 times the current users base of Afrezza, which translates to around 3,000 to 4,000 weekly refills. At that level, we are pretty close to break even. In other words, if every Endo prescribes Afrezza to 5% of his patients, we will break even.
|
|
|
Post by sportsrancho on Oct 19, 2016 14:55:48 GMT -5
Great point! ^^
|
|
|
Post by novafett on Oct 19, 2016 15:14:24 GMT -5
Something exciting comes along, i'm going to be excited. Screw any negativity on this board.
|
|
|
Post by dictatorsaurus on Oct 19, 2016 15:18:08 GMT -5
Something exciting comes along, i'm going to be excited. Screw any negativity on this board. You're confusing negativity with reality. Only thing that should be considered remotely close to exciting is anything that can move the needle or increase scripts. Everything else is purely self indulgence.
|
|
|
Post by ilovekauai on Oct 19, 2016 15:18:35 GMT -5
We still have a long way to go. Unfortunately, that doctor did little to aid the cause. IMO his statement that Afrezza will only be of use to a small group of diabetics seemed really out of place. There was no reason for him to make that subjective opinion. Why did he say that is what I'd like to know. Why didn't he talk about the greatly improved A1c levels patients are experiencing on Afrezza!
|
|
|
Post by radgray68 on Oct 19, 2016 15:19:56 GMT -5
Love to see any activity after such a long pause in the action. Always with the caution, those doctors. I had a funny thought, though. Doctors don't have to tell EVERY patient they come in contact with that 8% of people who stay at a hospital acquire additional nosocomial infections, costing on average 3 times the average treatment. They do tell everybody to go to the ER, though if they have something serious. Double standard? Meh. Just an observation.
However, as some have pointed out, being told you may not qualify for it may cause some to want it more, especially the smokers (I know from experience, 20 yrs. a slave to those evil little cancer causing ba--ards ) I would love to get 5% of the world market someday. This will have to do for a start. No matter what, I'll be able to say I was right about the science and the product.
|
|
|
Post by novafett on Oct 19, 2016 15:22:51 GMT -5
Something exciting comes along, i'm going to be excited. Screw any negativity on this board. You're confusing negativity with reality. Only thing that should be considered remotely close to exciting is anything that can move the needle or increase scripts. Everything else is purely self indulgence. Respectfully, like beauty, excitement is in the eye of the beholder.
|
|
|
Post by dictatorsaurus on Oct 19, 2016 15:47:51 GMT -5
You're confusing negativity with reality. Only thing that should be considered remotely close to exciting is anything that can move the needle or increase scripts. Everything else is purely self indulgence. Respectfully, like beauty, excitement is in the eye of the beholder. Fair enough
|
|
|
Post by sportsrancho on Oct 19, 2016 16:01:52 GMT -5
|
|
|
Post by mnholdem on Oct 19, 2016 16:15:07 GMT -5
Once the label changes are approved, news stories with interviews like this one can talk about why Afrezza is DIFFERENT in ways other than just inhaling. I think the first label upgrade will involve supplemental dosing after eating to improve control of high blood sugar. That one could be approved in 30 days. Getting the approval to upgrade the label to include new efficacy data will likely take longer. There has been a lot of post-marketing trial data released, so don't be surprised if Mannkind is submitting more than one application for label changes. FDA approval could happen soon on some of them. Marketing the new data will immediately follow.
You know, it wasn't all that long ago that MannKind issued a PR that it was joining with JDRF, who would be assisting in the development of the pediatric trial protocols. Since then we've heard nothing. Nothing! Why is that? Is the FDA holding everything up by delaying the trial negotiation? Or is MannKind responsible for these delays? What started out as a refreshing new era of transparency has collapsed behind a wall of secrecy again.
|
|
|
Post by broncolife on Oct 19, 2016 16:33:45 GMT -5
How come the longs will say they are long, but you bashers/shorts won't say your short? Have fun with your day jobs!! 😁
|
|
|
Post by mnkdorbust on Oct 19, 2016 16:38:51 GMT -5
Something exciting comes along, i'm going to be excited. Screw any negativity on this board. I'm excited it was a green day! It's the little things after all of the torture.
|
|
|
Post by sportsrancho on Oct 19, 2016 17:44:45 GMT -5
|
|
|
Post by sportsrancho on Oct 19, 2016 18:25:57 GMT -5
|
|
|
Post by sayhey24 on Oct 19, 2016 18:53:51 GMT -5
This was a great job in moving the ball forward. It would have been nice if they had talked to Laura's Dr. and not some guy whose only knowledge of afrezza seemed to be reading the label and saying - "Afrezza works as well as injectable fast-acting insulin, but it's harder to tweak the dosage and more expensive." I sure hope Mike C sent his sale manager right over to that guys office. One of the greatest benefits is not needing to tweak and be precise and this guy thinks its a negative. He said he had less than 5%. I wonder if he has any. Dr. Phil did a diabetic special last week. It would be nice to take Laura's experience to Dr. Phil and bring along Dr. Edelman and Daniele Hargenrader and give the live demo with the CGM, OJ and afrezza. Maybe Edelman talk about afrezza benefits and his work in helping to design the Onduo protocol.
|
|